SlideShare a Scribd company logo
1 of 42
Download to read offline
Basic measurements in
epidemiology
Prepared by
Krupa Mathew. M,
Assistant professor
2
Define epidemiology
The study of the distribution and determinants of health-related states or events in
specified population and the application of the study to control of health problems
(J.M. Last 1988)
Uses of epidemiology
οƒΌ Investigation of causation of disease.
οƒΌ Study of the natural history and prognosis of diseases.
οƒΌ Description of the health status of the populations.
οƒΌ It includes proportion with ill Health, change over time, change with age etc
οƒΌ Evaluation of the interventions.
οƒΌ Planning health services, Public policy and programs.
Measurements used in epidemiology
β€’ Measurement of mortality
β€’ Measurement of morbidity
β€’ Measurement of disability
β€’ Measurement of natality
β€’ Measurement of disease attributes
β€’ Measurement of health care services
β€’ Measurement of the risk factors
β€’ Measurement of demographic variables
Tools of
measurement
4
The epidemiologist usually expresses disease magnitude as a rate, ratio, proportion.
The basic tools of measurement in epidemiology are
β€’ Proportion
β€’ Rate
β€’ Ratio
Proportion
5
A part/share or number considered in comparative relation to a whole. Usually expressed as a percentage %.
This is also relation /magnitude between two quantities, and numerator is always part of denominator and
expressed as percentage
β€’ Usually expressed as a percentage %
– Numerator (which is part of denominator)
– Denominator
– Multiplier
– No time factor
Proportion – example
6
-Proportion of female students.
-Proportion of anaemic mothers (60% mothers are anaemic)
What proportion of the population is suffering from diabetes?
Rate
7
It Measures the occurrence of an event or disease in a given population during a given period (one Year).
(Birth rate, growth rate, accident rate). Usually expressed per 100 or per 1000 population. It has a time
dimension, whereas a PROPORTION does not.
Contains
β€’ Numerator (which is part of denominator)
β€’ Denominator
β€’ Multiplier
β€’ Time period
β€’ Usually expressed per 100 / per 1000 population
Rate – example
8
Death rate =
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ
π‘‡π‘œπ‘‘π‘Žπ‘™ 𝑝opπ‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› 𝑖𝑛 π‘‘β„Žπ‘Žπ‘‘ π‘¦π‘’π‘Žπ‘Ÿ
X 1000
Ratio
9
The value obtained by dividing one quantity by another - X / Y.
A ratio often compares two rates. Ratio also expresses relation of size between the two quantities.
Numerator is not part of Denominator.
Expressed as X / Y.
Examples:
οƒΌ Male to female ratio.
οƒΌ Doctor : Population ratio.
οƒΌ Male : Female ratio.
οƒΌ WBC : RBC ratio
MEASUREMENT
OF
MORTALITY
10
Measurement of mortality
11
Disease or injury that initiated the train of morbid
events leading directly to death.
β€’ Crude death rate
β€’ Specific death rate
β€’ Proportional mortality rate
β€’ Case fatality rate
β€’ Survival rate
β€’ Adjusted/standardized rates
Crude Death Rate
12
𝐢𝐷𝑅 = π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000
𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
It is defined as β€œthe number of deaths from all causes per 1000 estimated
mid-year population in one year, in a given place”.
The simplest measure of mortality is the crude death rate
Specific death rate
13
i. Cause specific
e.g. Deaths due to cholera
ii. Age specific
e.g. Infant deaths
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  due to cholera π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000
𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
π‘π‘œ.π‘œπ‘“ infants π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000
𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
When analysis planned to throw light on aetiology, it is essential to use specific death rates.
The specific death rates may be
(i) cause or disease specific eg. TB, cancer
(ii) related to specific groups eg. Age-specific, sex specific etc.,
β€’ Sex specific
e.g. Maternal deaths
β€’ Time specific
– Weekly deaths
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  among males π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ
X 1000
𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  in week X 52
X 1000
𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
PROPORTIONAL MORTALITY
RATE/RATIO
β€’ It helps to know what proportion of total deaths are due to a
particular cause(eg. cancer) or what proportion of deaths are
occurring in a particular age group (eg. above the age of 50yrs)
β€’ It expresses the number of deaths due to a particular cause (or in
a specific age group) per 100(or 1000) total deaths.
Proportional mortality rate
a. Proportional mortality rate from a specific disease
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑑𝑒𝑒 π‘‘π‘œ π‘Ž π‘π‘Žπ‘Ÿπ‘‘π‘–π‘π‘’π‘™π‘Žπ‘Ÿ π‘π‘œπ‘›π‘‘π‘–π‘‘π‘–π‘œπ‘› in a year
b. Under five proportionate mortality rate
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  from all causes in that year
X 100
π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  due to cholera π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000
Total no. of deaths during the same period
Case fatality rate
17
CFR = π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑑𝑒𝑒 π‘‘π‘œ a particular disease
X100
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘π‘Žπ‘ π‘’π‘  due to same disease
Survival rate
18
It is the proportion of survivors in a group, studied and followed over a period.
It is a method of describing prognosis in certain disease conditions.
β€’ Used in research studies
β€’ Like cancer therapy or survival
=
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘π‘Žπ‘‘π‘–π‘’π‘›π‘‘π‘ 
π‘ƒπ‘Žπ‘‘π‘–π‘’π‘›π‘‘π‘  π‘Žπ‘™π‘–π‘£π‘’ π‘Žπ‘‘ π‘‘β„Žπ‘’ 𝑒𝑛𝑑 π‘œπ‘“5 π‘¦π‘’π‘Žπ‘Ÿ X 100
ADJUSTED OR STANDARDIZED RATES
β€’ To compare the death rates of two populations with different age –
composition, the crude death rate is not the right yardstick.
β€’ Hence we are using the adjusted or standardized rates
β€’ The rate is either β€œage adjustment” or β€œage standardization” which
removes the confounding effect of different age structures and yields a
single standardized or adjusted rate, by which the mortality experience
can be compared directly.
β€’ Standardization is carried out by one of the two methods – direct or
indirect standardization. Both the methods begin by choosing a
standard population not the age-structures of the populations
Standardized mortality ratio
20
SMR =
Observed deaths
Expected deaths
X 100
Direct standardization
21
Indirect standardization
22
37
Total population
Total deaths – all causes
Cholera deaths
CDR
Specific DR
PMR
MEASUREMENT
OF
MORBIDITY
24
Measurements of morbidity
Morbidity is defined as β€œany departure, subjective or objective, from a state of
physiological well-being. The term is used equivalent to such terms as sickness,
illness, disability etc.
WHO Expert committee on Health statistics that morbidity could be measured in
terms of 3 aspects
(i) persons who were ill
(ii) the illness that these persons experienced
(iii)the duration of these illnesses
26
β€’ Incidence
– Occurrence of new cases
β€’ Prevalence
– Existence of new and old cases
β€’ Incidence – how many people with the disease are newly
diagnosed each year (like video)
β€’ Prevalence - how many people in a population currently have
the disease (like snapshot)
Incidence
27
No. of 𝐍𝐄𝐖 cases of a disease
Total population at risk during the same
time period
in a particular time period
X 1000
The incidence rate is defined as β€˜the number of NEW cases occurring in a defined
population during a specified period of time’.
Special incidence
rates
28
Attack rate:
The rate at which acute disease is spreading. It is used during
epidemics & expressed in %.
Secondary attack rate:
% of exposed persons developing disease after primary case
exposure.
Uses of incidence
rate
29
β€’ For taking action to control disease
β€’ More suited for acute or infectious conditions
β€’ For research
Example of use of
incidence
30
Points to remember about
incidence
31
β€’ Refers only to new cases
β€’ Not influenced by duration of disease
β€’ Refers to a particular time period
β€’ Denominator is people at risk
Prevalence
β€’ The term disease prevalence refers to specifically to all current
cases(old and new) existing at a given point in time, over a period of
time in a given population.
β€’ The total number of all individuals who have an attribute or disease at
a particular time divided by the population at risk of having the
attribute or disease at this point in time or midway through the period
Prevalence
33
=
No.of πŽπ‹πƒ 𝐚𝐧𝐝 𝐍𝐄𝐖 cases of a disease
Total population at risk during
the same time period
in a particular time point/period
X 1000
Types of prevalence
34
Point prevalence
Number all current cases at any given point of time. 4% TB cases on 1st April. It is defined as number of all
current cases (old and new) of a disease at one point of time, in relation to a defined population. The point in a
point prevalence, may for all practical purposes consists of a day, several days or even a few weeks depending
upon the time it takes to examine the population sample.
No of all cases (old & new) of a specified
disease existing at a given point in time X 100
Estimated population at the same point in time
Period prevalence
Number all current cases at a given period of time. A less commonly used measure of prevalence is period
prevalence. It measures the frequency of all current cases (old and new) existing during a defined period of time.
e.g (Annual Prevalence) expressed in relation to defined population. It includes cases arises before but extending
into or through to the year as well as those cases arising during the year.
No of all cases (old & new) of a specified
disease during a given period of time interval X 100
Estimated mid interval population at risk
Prevalence increases
35
β€’ Longer duration of disease
β€’ Prolongation of life with treatment
β€’ Increase in incidence
β€’ Immigration of new cases
β€’ Better reporting of cases
β€’ Emigration of healthy people
Prevalence decreases
36
β€’ Shorter duration of diseases
β€’ Improved cure rate
β€’ Decrease in incidence
β€’ Emigration of new cases
β€’ Under reporting of cases
β€’ Immigration of healthy people
Uses of prevalence
37
β€’ Magnitude of disease problems
β€’ Identify potential high-risk populations
β€’ Administrative and planning purposes, e.g., hospital beds,
manpower needs, rehabilitation facilities
Points to remember about prevalence
38
β€’ Refers to new and old cases
β€’ Influenced by duration of disease
β€’ Refers to a particular time period
β€’ Denominator is people at risk
Relation between incidence & prevalence
39
Relation between incidence & prevalence
40
β€’ Prevalence = Incidence X duration
β€’ Incidence = 10 cases/1000 population/year
β€’ Mean duration of disease = 5 years
β€’ Prevalence = 10 x 5 = 50 per 1000 population
USES OF MORBIDITY RATES
οƒΌ Give important clues for epidemiological research.
οƒΌ Assessment of public health problems and programs.
οƒΌ Designing intervention programs.
οƒΌ Indicating priorities for health action and resource allocation.
οƒΌ Explaining trends in overall mortality.
basicmeasurementsinepidemiology-201020073202.pdf

More Related Content

Similar to basicmeasurementsinepidemiology-201020073202.pdf

Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptxAbdallahAlasal1
Β 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptxAbdallahAlasal1
Β 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalDhan Pandey
Β 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxanjalatchi
Β 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityADIL .
Β 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptxDeepakRx1
Β 
Disease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxDisease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxSaeedAbdiali
Β 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdfSondosAli13
Β 
5 mortality and morbidity indicators
5 mortality and morbidity indicators5 mortality and morbidity indicators
5 mortality and morbidity indicatorsAnup Kharde
Β 
MORTALITY by RAM NAIK
MORTALITY by RAM NAIKMORTALITY by RAM NAIK
MORTALITY by RAM NAIKRam Naik M
Β 
Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptxradha maharjan
Β 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfteddiyfentaw
Β 
Unit 2
Unit 2Unit 2
Unit 2minusth
Β 
Epidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptxEpidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptxHinaBarkaat
Β 
Morbidity & mortality
Morbidity & mortalityMorbidity & mortality
Morbidity & mortalityHalyna Lugova
Β 
PRINCIPLE OF EPIDEMIOLOGY.pptx
PRINCIPLE OF  EPIDEMIOLOGY.pptxPRINCIPLE OF  EPIDEMIOLOGY.pptx
PRINCIPLE OF EPIDEMIOLOGY.pptxAyshaAlrawi1
Β 
2. Measurements of Morbidity and Mortality.pptx
2. Measurements of Morbidity and Mortality.pptx2. Measurements of Morbidity and Mortality.pptx
2. Measurements of Morbidity and Mortality.pptxFerhanKadir
Β 

Similar to basicmeasurementsinepidemiology-201020073202.pdf (20)

Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
Β 
Data and epidemiology 2.pptx
Data and epidemiology 2.pptxData and epidemiology 2.pptx
Data and epidemiology 2.pptx
Β 
Measuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlalMeasuring the occurrences of disease dhanlal
Measuring the occurrences of disease dhanlal
Β 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptx
Β 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
Β 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptx
Β 
Disease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxDisease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptx
Β 
3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf3. Measures of morbidity(1).pdf
3. Measures of morbidity(1).pdf
Β 
5 mortality and morbidity indicators
5 mortality and morbidity indicators5 mortality and morbidity indicators
5 mortality and morbidity indicators
Β 
MORTALITY by RAM NAIK
MORTALITY by RAM NAIKMORTALITY by RAM NAIK
MORTALITY by RAM NAIK
Β 
Measurement of epidemiology.pptx
Measurement of epidemiology.pptxMeasurement of epidemiology.pptx
Measurement of epidemiology.pptx
Β 
MM 2.pptx
MM 2.pptxMM 2.pptx
MM 2.pptx
Β 
mudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdfmudule 3 Measure of health and Health Related Events.pdf
mudule 3 Measure of health and Health Related Events.pdf
Β 
Unit 2
Unit 2Unit 2
Unit 2
Β 
Epidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptxEpidemiological Mehods [Autosaved].pptx
Epidemiological Mehods [Autosaved].pptx
Β 
Morbidity & mortality
Morbidity & mortalityMorbidity & mortality
Morbidity & mortality
Β 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
Β 
MM 2.pptx
MM 2.pptxMM 2.pptx
MM 2.pptx
Β 
PRINCIPLE OF EPIDEMIOLOGY.pptx
PRINCIPLE OF  EPIDEMIOLOGY.pptxPRINCIPLE OF  EPIDEMIOLOGY.pptx
PRINCIPLE OF EPIDEMIOLOGY.pptx
Β 
2. Measurements of Morbidity and Mortality.pptx
2. Measurements of Morbidity and Mortality.pptx2. Measurements of Morbidity and Mortality.pptx
2. Measurements of Morbidity and Mortality.pptx
Β 

More from NOKHAIZHAMMAD2021BSM

Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxNOKHAIZHAMMAD2021BSM
Β 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigNOKHAIZHAMMAD2021BSM
Β 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgNOKHAIZHAMMAD2021BSM
Β 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxNOKHAIZHAMMAD2021BSM
Β 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfNOKHAIZHAMMAD2021BSM
Β 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfNOKHAIZHAMMAD2021BSM
Β 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptxNOKHAIZHAMMAD2021BSM
Β 
LEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxLEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxNOKHAIZHAMMAD2021BSM
Β 
Death due to natural diseases.pdf
Death due to natural diseases.pdfDeath due to natural diseases.pdf
Death due to natural diseases.pdfNOKHAIZHAMMAD2021BSM
Β 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfNOKHAIZHAMMAD2021BSM
Β 
bloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxbloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxNOKHAIZHAMMAD2021BSM
Β 
edemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfedemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfNOKHAIZHAMMAD2021BSM
Β 

More from NOKHAIZHAMMAD2021BSM (20)

Developing a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptxDeveloping a Conceptual Framework for Research (1).pptx
Developing a Conceptual Framework for Research (1).pptx
Β 
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
GhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggigGhjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
Ghjagjhshfjsfijgsjhgjsgjhwhuwhiwghgwgiuwhuiggig
Β 
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient CareghhgjhgwugwghjsghjsgjsghusvhgshgPatient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Patient Careghhgjhgwugwghjsghjsgjsghusvhgshg
Β 
PN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptxPN Lesson 12 Communicating with Patients.pptx
PN Lesson 12 Communicating with Patients.pptx
Β 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
Β 
pptx (19).pptx
pptx (19).pptxpptx (19).pptx
pptx (19).pptx
Β 
Hematopiosis.pptx
Hematopiosis.pptxHematopiosis.pptx
Hematopiosis.pptx
Β 
bloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdfbloodcompositionanditsfunctionson17-170209014518.pdf
bloodcompositionanditsfunctionson17-170209014518.pdf
Β 
pptx.pptx
pptx.pptxpptx.pptx
pptx.pptx
Β 
chap004.ppt
chap004.pptchap004.ppt
chap004.ppt
Β 
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdfSUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
SUBHADIPA MAJUMDERHematopoiesis2022-07-22Hematopoiesis.pdf
Β 
Method of histological study L3.pptx
Method of histological study L3.pptxMethod of histological study L3.pptx
Method of histological study L3.pptx
Β 
LEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptxLEC 2 HISTO CELL MEMBRANE.pptx
LEC 2 HISTO CELL MEMBRANE.pptx
Β 
Death due to natural diseases.pdf
Death due to natural diseases.pdfDeath due to natural diseases.pdf
Death due to natural diseases.pdf
Β 
hdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptxhdnnonmlt-151222085444.pptx
hdnnonmlt-151222085444.pptx
Β 
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdfbloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
bloodcoagulationandclottingmechanism-221015163656-2f6797c3.pdf
Β 
bloodclotting-200418092606.pptx
bloodclotting-200418092606.pptxbloodclotting-200418092606.pptx
bloodclotting-200418092606.pptx
Β 
Autopsy1.pdf
Autopsy1.pdfAutopsy1.pdf
Autopsy1.pdf
Β 
Leukemia.pptx
Leukemia.pptxLeukemia.pptx
Leukemia.pptx
Β 
edemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdfedemabyahammednaseem-210628024050.pdf
edemabyahammednaseem-210628024050.pdf
Β 

Recently uploaded

How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
Β 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
Β 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
Β 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
Β 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
Β 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)Dr. Mazin Mohamed alkathiri
Β 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
Β 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
Β 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
Β 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
Β 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
Β 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
Β 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
Β 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
Β 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
Β 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
Β 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
Β 

Recently uploaded (20)

TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
Β 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
Β 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
Β 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)β€”β€”β€”β€”IMP.OF KSHARA ...
Β 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
Β 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
Β 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
Β 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
Β 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
Β 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
Β 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Β 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
Β 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
Β 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
Β 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
Β 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
Β 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
Β 
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Model Call Girl in Tilak Nagar Delhi reach out to us at πŸ”9953056974πŸ”
Β 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
Β 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
Β 

basicmeasurementsinepidemiology-201020073202.pdf

  • 1. Basic measurements in epidemiology Prepared by Krupa Mathew. M, Assistant professor
  • 2. 2 Define epidemiology The study of the distribution and determinants of health-related states or events in specified population and the application of the study to control of health problems (J.M. Last 1988) Uses of epidemiology οƒΌ Investigation of causation of disease. οƒΌ Study of the natural history and prognosis of diseases. οƒΌ Description of the health status of the populations. οƒΌ It includes proportion with ill Health, change over time, change with age etc οƒΌ Evaluation of the interventions. οƒΌ Planning health services, Public policy and programs.
  • 3. Measurements used in epidemiology β€’ Measurement of mortality β€’ Measurement of morbidity β€’ Measurement of disability β€’ Measurement of natality β€’ Measurement of disease attributes β€’ Measurement of health care services β€’ Measurement of the risk factors β€’ Measurement of demographic variables
  • 4. Tools of measurement 4 The epidemiologist usually expresses disease magnitude as a rate, ratio, proportion. The basic tools of measurement in epidemiology are β€’ Proportion β€’ Rate β€’ Ratio
  • 5. Proportion 5 A part/share or number considered in comparative relation to a whole. Usually expressed as a percentage %. This is also relation /magnitude between two quantities, and numerator is always part of denominator and expressed as percentage β€’ Usually expressed as a percentage % – Numerator (which is part of denominator) – Denominator – Multiplier – No time factor
  • 6. Proportion – example 6 -Proportion of female students. -Proportion of anaemic mothers (60% mothers are anaemic) What proportion of the population is suffering from diabetes?
  • 7. Rate 7 It Measures the occurrence of an event or disease in a given population during a given period (one Year). (Birth rate, growth rate, accident rate). Usually expressed per 100 or per 1000 population. It has a time dimension, whereas a PROPORTION does not. Contains β€’ Numerator (which is part of denominator) β€’ Denominator β€’ Multiplier β€’ Time period β€’ Usually expressed per 100 / per 1000 population
  • 8. Rate – example 8 Death rate = π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ π‘‡π‘œπ‘‘π‘Žπ‘™ 𝑝opπ‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› 𝑖𝑛 π‘‘β„Žπ‘Žπ‘‘ π‘¦π‘’π‘Žπ‘Ÿ X 1000
  • 9. Ratio 9 The value obtained by dividing one quantity by another - X / Y. A ratio often compares two rates. Ratio also expresses relation of size between the two quantities. Numerator is not part of Denominator. Expressed as X / Y. Examples: οƒΌ Male to female ratio. οƒΌ Doctor : Population ratio. οƒΌ Male : Female ratio. οƒΌ WBC : RBC ratio
  • 11. Measurement of mortality 11 Disease or injury that initiated the train of morbid events leading directly to death. β€’ Crude death rate β€’ Specific death rate β€’ Proportional mortality rate β€’ Case fatality rate β€’ Survival rate β€’ Adjusted/standardized rates
  • 12. Crude Death Rate 12 𝐢𝐷𝑅 = π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000 𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› It is defined as β€œthe number of deaths from all causes per 1000 estimated mid-year population in one year, in a given place”. The simplest measure of mortality is the crude death rate
  • 13. Specific death rate 13 i. Cause specific e.g. Deaths due to cholera ii. Age specific e.g. Infant deaths π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  due to cholera π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000 𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘π‘œ.π‘œπ‘“ infants π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000 𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› When analysis planned to throw light on aetiology, it is essential to use specific death rates. The specific death rates may be (i) cause or disease specific eg. TB, cancer (ii) related to specific groups eg. Age-specific, sex specific etc.,
  • 14. β€’ Sex specific e.g. Maternal deaths β€’ Time specific – Weekly deaths π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  among males π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000 𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  in week X 52 X 1000 𝑀𝑖𝑑 π‘¦π‘’π‘Žπ‘Ÿ π‘π‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
  • 15. PROPORTIONAL MORTALITY RATE/RATIO β€’ It helps to know what proportion of total deaths are due to a particular cause(eg. cancer) or what proportion of deaths are occurring in a particular age group (eg. above the age of 50yrs) β€’ It expresses the number of deaths due to a particular cause (or in a specific age group) per 100(or 1000) total deaths.
  • 16. Proportional mortality rate a. Proportional mortality rate from a specific disease π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑑𝑒𝑒 π‘‘π‘œ π‘Ž π‘π‘Žπ‘Ÿπ‘‘π‘–π‘π‘’π‘™π‘Žπ‘Ÿ π‘π‘œπ‘›π‘‘π‘–π‘‘π‘–π‘œπ‘› in a year b. Under five proportionate mortality rate π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  from all causes in that year X 100 π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  due to cholera π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘œπ‘›π‘’ π‘¦π‘’π‘Žπ‘Ÿ X 1000 Total no. of deaths during the same period
  • 17. Case fatality rate 17 CFR = π‘π‘œ.π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑑𝑒𝑒 π‘‘π‘œ a particular disease X100 π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘π‘Žπ‘ π‘’π‘  due to same disease
  • 18. Survival rate 18 It is the proportion of survivors in a group, studied and followed over a period. It is a method of describing prognosis in certain disease conditions. β€’ Used in research studies β€’ Like cancer therapy or survival = π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ.π‘œπ‘“ π‘π‘Žπ‘‘π‘–π‘’π‘›π‘‘π‘  π‘ƒπ‘Žπ‘‘π‘–π‘’π‘›π‘‘π‘  π‘Žπ‘™π‘–π‘£π‘’ π‘Žπ‘‘ π‘‘β„Žπ‘’ 𝑒𝑛𝑑 π‘œπ‘“5 π‘¦π‘’π‘Žπ‘Ÿ X 100
  • 19. ADJUSTED OR STANDARDIZED RATES β€’ To compare the death rates of two populations with different age – composition, the crude death rate is not the right yardstick. β€’ Hence we are using the adjusted or standardized rates β€’ The rate is either β€œage adjustment” or β€œage standardization” which removes the confounding effect of different age structures and yields a single standardized or adjusted rate, by which the mortality experience can be compared directly. β€’ Standardization is carried out by one of the two methods – direct or indirect standardization. Both the methods begin by choosing a standard population not the age-structures of the populations
  • 20. Standardized mortality ratio 20 SMR = Observed deaths Expected deaths X 100
  • 23. 37 Total population Total deaths – all causes Cholera deaths CDR Specific DR PMR
  • 25. Measurements of morbidity Morbidity is defined as β€œany departure, subjective or objective, from a state of physiological well-being. The term is used equivalent to such terms as sickness, illness, disability etc. WHO Expert committee on Health statistics that morbidity could be measured in terms of 3 aspects (i) persons who were ill (ii) the illness that these persons experienced (iii)the duration of these illnesses
  • 26. 26 β€’ Incidence – Occurrence of new cases β€’ Prevalence – Existence of new and old cases β€’ Incidence – how many people with the disease are newly diagnosed each year (like video) β€’ Prevalence - how many people in a population currently have the disease (like snapshot)
  • 27. Incidence 27 No. of 𝐍𝐄𝐖 cases of a disease Total population at risk during the same time period in a particular time period X 1000 The incidence rate is defined as β€˜the number of NEW cases occurring in a defined population during a specified period of time’.
  • 28. Special incidence rates 28 Attack rate: The rate at which acute disease is spreading. It is used during epidemics & expressed in %. Secondary attack rate: % of exposed persons developing disease after primary case exposure.
  • 29. Uses of incidence rate 29 β€’ For taking action to control disease β€’ More suited for acute or infectious conditions β€’ For research
  • 30. Example of use of incidence 30
  • 31. Points to remember about incidence 31 β€’ Refers only to new cases β€’ Not influenced by duration of disease β€’ Refers to a particular time period β€’ Denominator is people at risk
  • 32. Prevalence β€’ The term disease prevalence refers to specifically to all current cases(old and new) existing at a given point in time, over a period of time in a given population. β€’ The total number of all individuals who have an attribute or disease at a particular time divided by the population at risk of having the attribute or disease at this point in time or midway through the period
  • 33. Prevalence 33 = No.of πŽπ‹πƒ 𝐚𝐧𝐝 𝐍𝐄𝐖 cases of a disease Total population at risk during the same time period in a particular time point/period X 1000
  • 34. Types of prevalence 34 Point prevalence Number all current cases at any given point of time. 4% TB cases on 1st April. It is defined as number of all current cases (old and new) of a disease at one point of time, in relation to a defined population. The point in a point prevalence, may for all practical purposes consists of a day, several days or even a few weeks depending upon the time it takes to examine the population sample. No of all cases (old & new) of a specified disease existing at a given point in time X 100 Estimated population at the same point in time Period prevalence Number all current cases at a given period of time. A less commonly used measure of prevalence is period prevalence. It measures the frequency of all current cases (old and new) existing during a defined period of time. e.g (Annual Prevalence) expressed in relation to defined population. It includes cases arises before but extending into or through to the year as well as those cases arising during the year. No of all cases (old & new) of a specified disease during a given period of time interval X 100 Estimated mid interval population at risk
  • 35. Prevalence increases 35 β€’ Longer duration of disease β€’ Prolongation of life with treatment β€’ Increase in incidence β€’ Immigration of new cases β€’ Better reporting of cases β€’ Emigration of healthy people
  • 36. Prevalence decreases 36 β€’ Shorter duration of diseases β€’ Improved cure rate β€’ Decrease in incidence β€’ Emigration of new cases β€’ Under reporting of cases β€’ Immigration of healthy people
  • 37. Uses of prevalence 37 β€’ Magnitude of disease problems β€’ Identify potential high-risk populations β€’ Administrative and planning purposes, e.g., hospital beds, manpower needs, rehabilitation facilities
  • 38. Points to remember about prevalence 38 β€’ Refers to new and old cases β€’ Influenced by duration of disease β€’ Refers to a particular time period β€’ Denominator is people at risk
  • 39. Relation between incidence & prevalence 39
  • 40. Relation between incidence & prevalence 40 β€’ Prevalence = Incidence X duration β€’ Incidence = 10 cases/1000 population/year β€’ Mean duration of disease = 5 years β€’ Prevalence = 10 x 5 = 50 per 1000 population
  • 41. USES OF MORBIDITY RATES οƒΌ Give important clues for epidemiological research. οƒΌ Assessment of public health problems and programs. οƒΌ Designing intervention programs. οƒΌ Indicating priorities for health action and resource allocation. οƒΌ Explaining trends in overall mortality.